BLFS
NASDAQBioLife Solutions Inc.
SectorHealth CareIndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
Website
News25/Ratings8
News · 26 weeks72-62%
2025-10-262026-04-19
Mix3990d
- Insider31(79%)
- Other3(8%)
- Earnings3(8%)
- SEC Filings2(5%)
Latest news
25 items- PRBioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026BOTHELL, Wash., April 23, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2026 first quarter financial results will be released on May 7, 2026. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update. To access the webcast, log onto the Investor Relations page of the BioLife Solutions websit
- PRBioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCaseAward Recognizes Technologies That Address Important Industry Needs and Advance Prior StandardsBOTHELL, Wash., April 21, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced it has received the INTERPHEX 2026 Biotech Innovation Award for its CellSeal® CryoCase, a rigid cryogenic containment system purpose-built for frozen biologic materials. CellSeal CryoCase was developed in response to documented container failures in CGT manufacturing,
- INSIDERSEC Form 4 filed by Mathew Aby J.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Berard Todd4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Wichterman Troy4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Foster Karen A.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by BioLife Solutions Inc.SCHEDULE 13G/A - BIOLIFE SOLUTIONS INC (0000834365) (Subject)
- INSIDERSEC Form 4 filed by De Greef Roderick4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Berard Todd4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Werner Sean4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Wichterman Troy4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Foster Karen A.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Aebersold Sarah4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERSEC Form 4 filed by Mathew Aby J.4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERChief Quality and Operations Foster Karen A. sold $1,962,998 worth of shares (97,423 units at $20.15), decreasing direct ownership by 46% to 113,242 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERChief Technology Officer Werner Sean sold $2,302 worth of shares (111 units at $20.74), decreasing direct ownership by 0.22% to 49,932 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERChief Quality and Operations Foster Karen A. sold $8,669 worth of shares (418 units at $20.74), decreasing direct ownership by 0.20% to 210,665 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDEREVP & Chief Scientific Officer Mathew Aby J. sold $10,971 worth of shares (529 units at $20.74), decreasing direct ownership by 0.13% to 392,937 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERChief Financial Officer Wichterman Troy sold $12,195 worth of shares (588 units at $20.74), decreasing direct ownership by 0.27% to 220,649 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERChief Marketing Officer Berard Todd sold $7,321 worth of shares (353 units at $20.74), decreasing direct ownership by 0.21% to 165,940 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERChief Human Resources Officer Aebersold Sarah sold $4,542 worth of shares (219 units at $20.74), decreasing direct ownership by 0.23% to 93,360 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- SECBioLife Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - BIOLIFE SOLUTIONS INC (0000834365) (Filer)
- INSIDERChief Marketing Officer Berard Todd was granted 42,575 shares and covered exercise/tax liability with 8,846 shares, increasing direct ownership by 25% to 166,293 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERDirector Duross Amy was granted 8,170 shares, increasing direct ownership by 44% to 26,857 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)
- INSIDERChief Financial Officer Wichterman Troy covered exercise/tax liability with 25,525 shares and was granted 96,016 shares, increasing direct ownership by 47% to 221,237 units (SEC Form 4)4 - BIOLIFE SOLUTIONS INC (0000834365) (Issuer)